Log in

Aytu Bioscience News Headlines (NASDAQ:AYTU)

$1.21
0.00 (0.00 %)
(As of 10/15/2019 08:24 AM ET)
Today's Range
$1.21
Now: $1.21
$1.31
50-Day Range
$0.98
MA: $1.30
$1.48
52-Week Range
$0.68
Now: $1.21
$2.61
Volume154,288 shs
Average Volume160,179 shs
Market Capitalization$21.40 million
P/E RatioN/A
Dividend YieldN/A
Beta4.64

Headlines

Aytu Bioscience (NASDAQ AYTU) News Headlines

Source:
DateHeadline
Aytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Commercial Portfolio Acquisition Overview Conference (Transcript)Aytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Commercial Portfolio Acquisition Overview Conference (Transcript)
seekingalpha.com - October 14 at 10:33 PM
BRIEF-Cerecor To Sell Pediatric Portfolio To AYTU BioscienceBRIEF-Cerecor To Sell Pediatric Portfolio To AYTU Bioscience
www.msn.com - October 14 at 10:33 PM
Aytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Commercial Portfolio Acquisition Overview Conference - Slide PresentationAytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Commercial Portfolio Acquisition Overview Conference - Slide Presentation
seekingalpha.com - October 14 at 10:33 PM
Aytu BioScience, Inc.: Aytu BioScience Acquires $12.4 Million Prescription Product PortfolioAytu BioScience, Inc.: Aytu BioScience Acquires $12.4 Million Prescription Product Portfolio
www.finanznachrichten.de - October 14 at 7:31 AM
Aytu BioScience Announces $10 Million Private PlacementAytu BioScience Announces $10 Million Private Placement
finance.yahoo.com - October 14 at 7:31 AM
Aytu BioScience Acquires $12.4 Million Prescription Product PortfolioAytu BioScience Acquires $12.4 Million Prescription Product Portfolio
finance.yahoo.com - October 14 at 7:31 AM
Aytu Bioscience Inc (NASDAQ:AYTU) Sees Significant Decrease in Short InterestAytu Bioscience Inc (NASDAQ:AYTU) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - October 13 at 6:56 AM
Aytu BioScience and Validus Pharmaceuticals Announce ZolpiMist Co-Promotion Agreement and Launch Into the $163 Million Psychiatry MarketAytu BioScience and Validus Pharmaceuticals Announce ZolpiMist Co-Promotion Agreement and Launch Into the $163 Million Psychiatry Market
finance.yahoo.com - October 2 at 8:17 AM
Northland Securities Reiterates $10.00 Price Target for Aytu Bioscience (NASDAQ:AYTU)Northland Securities Reiterates $10.00 Price Target for Aytu Bioscience (NASDAQ:AYTU)
www.americanbankingnews.com - September 30 at 7:20 PM
Aytu Bioscience (NASDAQ:AYTU) Issues  Earnings ResultsAytu Bioscience (NASDAQ:AYTU) Issues Earnings Results
www.americanbankingnews.com - September 27 at 8:13 AM
Aytu BioScience, Inc.: Aytu BioScience Reports 100% Revenue Growth to $7.3 million in FY 2019Aytu BioScience, Inc.: Aytu BioScience Reports 100% Revenue Growth to $7.3 million in FY 2019
www.finanznachrichten.de - September 26 at 6:01 PM
Aytu BioScience Reports 100% Revenue Growth to $7.3 million in FY 2019Aytu BioScience Reports 100% Revenue Growth to $7.3 million in FY 2019
finance.yahoo.com - September 26 at 6:00 PM
Aytu BioScience (AYTU) Presents at Ladenburg Thalmann 2019 Healthcare Conference - Slide PresentationAytu BioScience (AYTU) Presents at Ladenburg Thalmann 2019 Healthcare Conference - Slide Presentation
seekingalpha.com - September 24 at 12:57 PM
Aytu BioScience Announces Addition of Natesto(R) to Leading National Pharmacy Benefit Manager’s Formulary; Natesto Added to Commercial Plans Covering Over 30 Million U.S. LivesAytu BioScience Announces Addition of Natesto(R) to Leading National Pharmacy Benefit Manager’s Formulary; Natesto Added to Commercial Plans Covering Over 30 Million U.S. Lives
finance.yahoo.com - September 24 at 12:57 PM
Aytu BioScience, Inc.: Aytu BioScience to Report Fiscal FY 2019 Results and Business UpdateAytu BioScience, Inc.: Aytu BioScience to Report Fiscal FY 2019 Results and Business Update
www.finanznachrichten.de - September 20 at 8:35 PM
Aytu BioScience to Report Fiscal FY 2019 Results and Business UpdateAytu BioScience to Report Fiscal FY 2019 Results and Business Update
finance.yahoo.com - September 20 at 8:35 PM
Zacks: Aytu Bioscience Inc (NASDAQ:AYTU) Given Average Recommendation of "Strong Buy" by BrokeragesZacks: Aytu Bioscience Inc (NASDAQ:AYTU) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - September 20 at 6:33 AM
Aytu BioScience, Inc.: Aytu BioScience to Present at Ladenburg Thalmann 2019 Healthcare ConferenceAytu BioScience, Inc.: Aytu BioScience to Present at Ladenburg Thalmann 2019 Healthcare Conference
www.finanznachrichten.de - September 17 at 9:14 AM
Aytu BioScience to Present at Ladenburg Thalmann 2019 Healthcare ConferenceAytu BioScience to Present at Ladenburg Thalmann 2019 Healthcare Conference
finance.yahoo.com - September 17 at 9:14 AM
Aytu BioScience, Inc.: Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in South AfricaAytu BioScience, Inc.: Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in South Africa
www.finanznachrichten.de - September 10 at 8:31 AM
Aytu Bio launches MiOXSYS male infertility test in South AfricaAytu Bio launches MiOXSYS male infertility test in South Africa
seekingalpha.com - September 10 at 8:31 AM
Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in South AfricaAytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in South Africa
finance.yahoo.com - September 10 at 8:31 AM
Do Insiders Own Lots Of Shares In Aytu BioScience, Inc. (NASDAQ:AYTU)?Do Insiders Own Lots Of Shares In Aytu BioScience, Inc. (NASDAQ:AYTU)?
finance.yahoo.com - September 5 at 8:17 PM
Aytu BioScience, Inc.: Aytu BioScience Announces Tuzistra XR Co-Promotion Agreement with Poly PharmaceuticalsAytu BioScience, Inc.: Aytu BioScience Announces Tuzistra XR Co-Promotion Agreement with Poly Pharmaceuticals
www.finanznachrichten.de - September 4 at 12:24 PM
Aytu BioScience Announces Tuzistra XR Co-Promotion Agreement with Poly PharmaceuticalsAytu BioScience Announces Tuzistra XR Co-Promotion Agreement with Poly Pharmaceuticals
finance.yahoo.com - September 4 at 12:24 PM
Whats in Store for Aytu BioSciences (AYTU) Q4 Earnings?What's in Store for Aytu BioScience's (AYTU) Q4 Earnings?
finance.yahoo.com - August 16 at 6:01 PM
What's in Store for Aytu BioScience's (AYTU) Q4 Earnings?What's in Store for Aytu BioScience's (AYTU) Q4 Earnings?
finance.yahoo.com - August 16 at 6:01 PM
Aytu BioScience Announces First ZolpiMist(TM) Clinical Study Results Demonstrating More Rapid Sleep Onset with Lingual Spray Zolpidem versus Oral TabletAytu BioScience Announces First ZolpiMist(TM) Clinical Study Results Demonstrating More Rapid Sleep Onset with Lingual Spray Zolpidem versus Oral Tablet
finance.yahoo.com - August 5 at 5:56 PM
Aytu BioScience (Nasdaq:CM AYTU) Gets Huge Deal With Acerus For Natesto® ExpansionAytu BioScience (Nasdaq:CM AYTU) Gets Huge Deal With Acerus For Natesto® Expansion
www.benzinga.com - August 1 at 10:44 PM
Aytu Bio up 9% premarket on beefed up commercial plan for NatestoAytu Bio up 9% premarket on beefed up commercial plan for Natesto
seekingalpha.com - July 30 at 9:44 AM
Aytu BioScience Expands Natesto(R) Partnership with Acerus Pharmaceuticals to Accelerate Natesto Growth in the U.S.Aytu BioScience Expands Natesto(R) Partnership with Acerus Pharmaceuticals to Accelerate Natesto Growth in the U.S.
finance.yahoo.com - July 30 at 9:44 AM
Natesto(R) Added to National Pharmacy Benefit Managers Formulary Natesto Now Covered on Payer Plans Covering Over 6 Million U.S. LivesNatesto(R) Added to National Pharmacy Benefit Manager's Formulary Natesto Now Covered on Payer Plans Covering Over 6 Million U.S. Lives
finance.yahoo.com - July 24 at 5:47 PM
VIDEO REPORT: Aytu BioScience AYTU Heats Up The Summer With Natesto and MiOXSYS Updates; Pipeline Has Billion Dollar Market PotentialVIDEO REPORT: Aytu BioScience AYTU Heats Up The Summer With Natesto and MiOXSYS Updates; Pipeline Has Billion Dollar Market Potential
www.marketwatch.com - July 11 at 4:59 PM
Aytu BioScience Shares Clinical Results For Natesto Testosterone MedicationAytu BioScience Shares Clinical Results For Natesto Testosterone Medication
finance.yahoo.com - July 8 at 5:16 PM
Aytu Bio up 8% premarket on encouraging Natesto dataAytu Bio up 8% premarket on encouraging Natesto data
seekingalpha.com - July 8 at 9:46 AM
Aytu BioScience Announces Publication of Clinical Study Results Demonstrating Effectiveness of Natesto(R) Regardless of Patients’ Baseline Hypogonadism SeverityAytu BioScience Announces Publication of Clinical Study Results Demonstrating Effectiveness of Natesto(R) Regardless of Patients’ Baseline Hypogonadism Severity
finance.yahoo.com - July 8 at 9:46 AM
Aytu BioScience Added to Russell Microcap(R) IndexAytu BioScience Added to Russell Microcap(R) Index
finance.yahoo.com - July 1 at 9:53 AM
Aytu BioScience Announces First Clinical Results Demonstrating Clinical Utility of MiOXSYS Male Infertility Test When Used Prior to In Vitro Fertilization (IVF) ProceduresAytu BioScience Announces First Clinical Results Demonstrating Clinical Utility of MiOXSYS Male Infertility Test When Used Prior to In Vitro Fertilization (IVF) Procedures
finance.yahoo.com - June 25 at 9:48 AM
MiOXSYS(R) Male Infertility Test Will be Featured in Product Theatre Symposium at 35th Annual Meeting of the European Society of Human Reproduction and EmbryologyMiOXSYS(R) Male Infertility Test Will be Featured in Product Theatre Symposium at 35th Annual Meeting of the European Society of Human Reproduction and Embryology
finance.yahoo.com - June 24 at 5:50 PM
Aytu BioScience Announces Presentation of Novel Clinical Findings for its Proprietary MiOXSYS(R) Male Infertility Test at Global Reproductive Medicine Scientific ConferenceAytu BioScience Announces Presentation of Novel Clinical Findings for its Proprietary MiOXSYS(R) Male Infertility Test at Global Reproductive Medicine Scientific Conference
finance.yahoo.com - June 18 at 6:40 PM
Aytu BioScience, Inc.: Aytu BioScience Featured in Local NBC News Segment (VIDEO): Nasal Spray for Low Testosterone Preserves FertilityAytu BioScience, Inc.: Aytu BioScience Featured in Local NBC News Segment (VIDEO): 'Nasal Spray for Low Testosterone Preserves Fertility'
www.finanznachrichten.de - June 12 at 1:10 PM
Aytu BioScience Featured in Local NBC News Segment (VIDEO): Nasal Spray for Low Testosterone Preserves FertilityAytu BioScience Featured in Local NBC News Segment (VIDEO): ''Nasal Spray for Low Testosterone Preserves Fertility''
finance.yahoo.com - June 12 at 1:10 PM
Aytu BioScience, Inc.: Aytu BioScience Set to Join Russell Microcap (R) IndexAytu BioScience, Inc.: Aytu BioScience Set to Join Russell Microcap (R) Index
www.finanznachrichten.de - June 11 at 10:38 AM
Aytu Bio to join Russell Microcap IndexAytu Bio to join Russell Microcap Index
seekingalpha.com - June 11 at 10:38 AM
Aytu BioScience Set to Join Russell Microcap (R) IndexAytu BioScience Set to Join Russell Microcap (R) Index
finance.yahoo.com - June 11 at 10:38 AM
Aytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in ChinaAytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in China
finance.yahoo.com - June 4 at 9:59 AM
Is Aytu Bioscience (AYTU) Outperforming Other Medical Stocks This Year?Is Aytu Bioscience (AYTU) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 30 at 5:28 PM
Aytu Bios Mioxsys male infertility test available in UKAytu Bio's Mioxsys male infertility test available in UK
seekingalpha.com - May 21 at 5:56 PM
Aytu BioScience, Inc.: Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in the United KingdomAytu BioScience, Inc.: Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in the United Kingdom
www.finanznachrichten.de - May 21 at 8:27 AM
Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in the United KingdomAytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in the United Kingdom
finance.yahoo.com - May 21 at 8:27 AM
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: What is basic economics?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel